NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma.
Saved in:
| Title: | NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma. |
|---|---|
| Authors: | Jones MR; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Williamson LM; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Topham JT; Pancreas Centre British Columbia, Vancouver, Canada., Lee MKC; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada., Goytain A; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Ho J; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Denroche RE; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Jang G; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Pleasance E; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Shen Y; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Karasinska JM; Pancreas Centre British Columbia, Vancouver, Canada., McGhie JP; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada., Gill S; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada., Lim HJ; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada., Moore MJ; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Wong HL; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada., Ng T; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Yip S; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Zhang W; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Sadeghi S; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Reisle C; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Mungall AJ; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Mungall KL; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Moore RA; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Ma Y; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Knox JJ; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Gallinger S; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada., Laskin J; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada., Marra MA; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Schaeffer DF; Pancreas Centre British Columbia, Vancouver, Canada.; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Jones SJM; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Vancouver, British Columbia, Canada., Renouf DJ; Pancreas Centre British Columbia, Vancouver, Canada. drenouf@bccancer.bc.ca.; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Aug 01; Vol. 25 (15), pp. 4674-4681. Date of Electronic Publication: 2019 May 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
